DR. DAVID W. MCALLISTER, M.D.

Plain English
This study looked at glioblastoma, a severe type of brain cancer, among patients in New Zealand diagnosed in 2021. Researchers found that the overall incidence was 3.6 cases per 100,000 people, with lower rates in Māori at 2.5 per 100,000 compared to 3.8 for non-Māori. The average survival time for patients was about 10.6 months, but those who had surgery to remove the tumor lived longer, with a median survival of 20 months, compared to just 4 months for those who only had a biopsy. Who this helps: This information aids doctors and healthcare providers in understanding glioblastoma trends and treatment effectiveness, ultimately benefiting patients with this diagnosis.

Plain English
This study looked at a cooling technique for the heads of stroke patients during a specific treatment called endovascular thrombectomy (EVT) to see if it was feasible. Out of 40 patients, 39 (97.5%) were able to tolerate the cooling for most of the treatment time, and 95% achieved good blood flow restoration after the procedure. This is significant because it suggests that cooling might help protect the brain during stroke treatment, resulting in better recovery outcomes. Who this helps: This helps stroke patients undergoing treatment and their doctors.

Plain English
This study examined the impact of socio-economic status on life expectancy and healthcare costs for people newly diagnosed with type 2 diabetes (T2DM) in Scotland. Researchers analyzed data from nearly 270,000 individuals diagnosed between 2004 and 2020, finding that men diagnosed at age 50 from the most deprived areas can expect to live about 26.7 more years, costing around £273,000 in healthcare. The study highlights the disparities in health outcomes and costs associated with T2DM based on socio-economic factors, which is crucial for shaping health policies and resource allocation. Who this helps: This benefits patients and healthcare policymakers.

Plain English
Researchers created a new tool called the Sport Publication Observation Research Tool (SPORT) to evaluate how well observational studies in sports medicine are conducted. After reviewing 55 studies, they found that the average quality score was 20 out of a possible higher score, indicating many studies may not be very high quality. This tool is important because it helps ensure that the research used in sports medicine reviews is reliable and trustworthy. Who this helps: This helps patients and doctors by ensuring they have access to high-quality research when making treatment decisions.

Plain English
This study looked at how different participant and trial features affect dropout rates in clinical trials. The researchers reviewed 88 other studies (covering 33 different health conditions) and found that most focused on features like participant age and sex, along with details about the type and delivery of treatments. About 57% of the reviews specifically examined psychological trials, showing that certain traits, like age and treatment type, might be linked to who drops out of trials, but no characteristics were consistently linked across all conditions. Who this helps: This helps researchers and doctors better understand who stays in or leaves clinical trials, improving the reliability of trial results.

Plain English
This study looked at whether using certain anesthetics, which carry warnings from the FDA, affects the intelligence of extremely premature infants at age 5. Out of 387 infants studied, 110 had been exposed to these anesthetics, but the researchers found no significant difference in IQ scores between those who were exposed and those who were not. This matters because it suggests that exposure to these warned anesthetics may not negatively impact long-term cognitive development in these vulnerable infants. Who this helps: This helps doctors and parents of premature infants.

Plain English
This study focused on improving the clarity of images taken with microscopes, especially when the images have distortions. Researchers developed a new method called ring deconvolution microscopy that uses the natural symmetry of microscopes, leading to faster processing and better image quality. They found that this new method enhances images significantly compared to traditional techniques, achieving subcellular resolution for different types of microscopy. Who this helps: This benefits researchers and scientists who need high-quality microscope images for their studies.

Plain English
This study looked at data from 90 clinical trials involving over 86,000 participants to understand why and when people drop out of these trials. They found that about 17% of participants left their trials, with the most common reasons being adverse effects (44%) and voluntarily choosing to leave (24%). Knowing when and why participants drop out helps improve how trials are designed and conducted, leading to more reliable results. Who this helps: This benefits researchers and healthcare providers by improving clinical trials and ultimately patient care.

Plain English
This study explored the use of a cooling cap to lower the temperature of the head in stroke patients before and during a type of treatment called endovascular thrombectomy. Out of 40 patients, 97.5% were able to tolerate the cooling for at least half the procedure time, and 95% showed good blood flow recovery after treatment. This matters because it suggests that cooling might be a safe and effective way to protect brain tissue during stroke treatment. Who this helps: Patients who suffer from ischemic strokes.

Plain English
This study looked at how surgery affects the growth of high-risk neuroblastoma tumors in mice. It found that surgery actually speeds up tumor growth, with a significant increase in growth rates when compared to mice that did not undergo surgery. However, treating the mice with a substance called poly(I:C) before and after surgery helped counteract this effect, suggesting that improving the immune response can be beneficial. Who this helps: This research can benefit children with high-risk neuroblastoma by leading to better treatment strategies during and after surgery.

Plain English
This study looked at how well clinical trials for a diabetes medication, sodium-glucose cotransporter-2 inhibitors (SGLT2i), reflect the real-world patients who use this treatment in Wales. Researchers compared data from 25 trials with a routine care database and found that trial participants had fewer health issues than those receiving treatment in the community. Specifically, while people with multiple health conditions were often excluded from trials, major cardiovascular trials showed similar rates of serious health events as those observed in everyday clinical settings, indicating that these larger trials may be more relevant to actual patients. Who this helps: This benefits patients with type 2 diabetes and their healthcare providers.

Plain English
This study focused on a type of blood cancer called acute myeloid leukemia (AML) and how a special version of a protein called CXCL12 (CXCL12-LD) affects the movement of cancer cells. Researchers found that CXCL12-LD, unlike other versions of CXCL12, did not promote movement of AML cells but instead helped pull these cells into the bloodstream more effectively in mice. This is important because it could lead to new treatments that can more effectively target AML cells, potentially improving patient outcomes. Who this helps: This helps patients with acute myeloid leukemia.

Plain English
This study focused on a new version of the CXCL12 protein, called CXCL12-LD, and its effects on acute myeloid leukemia (AML) cells. Researchers found that CXCL12-LD reduced the movement of AML cells compared to normal CXCL12 but increased the internalization of the receptor they target, which could help in moving more leukemia stem cells into the bloodstream in mice. This is important because it suggests a new way to make existing treatments more effective by better targeting cancer cells and addressing their resistance to current therapies. Who this helps: This helps patients with acute myeloid leukemia by potentially improving treatment outcomes.

Plain English
In this study, researchers looked at a new treatment called CCL20LD, designed to target a specific protein involved in immune response without causing unwanted side effects. They found that giving this treatment daily for 14 days did not lead to weight loss or immune issues, and only caused minor effects on certain immune responses at higher doses. This is important because it shows that CCL20LD could be a safe option for treating diseases related to the CCL20-CCR6 pathway, such as psoriasis or psoriatic arthritis. Who this helps: This helps patients with psoriasis and psoriatic arthritis.

Plain English
This study looked at how social factors, specifically levels of deprivation in living conditions, affect the risk of heart failure in patients with type 2 diabetes. Researchers found that among over a million patients studied, the chance of hospitalization for heart failure over five years was much lower for those in the least deprived areas (3.18%) compared to those in the most deprived areas (11%). This is important because it shows that considering social factors when predicting heart failure risk makes assessments more accurate. Who this helps: This helps doctors better identify which diabetes patients are at higher risk for heart failure based on their living conditions.

Plain English
This study looked at whether mothers getting epidural pain relief during labor affects the development of preterm infants born before 29 weeks of pregnancy. The researchers analyzed data from 669 infants, finding that those whose mothers received epidurals were not more likely to face developmental problems or death by age three compared to those whose mothers did not. This is important because it suggests that using epidurals during labor does not harm the long-term development of extremely premature infants. Who this helps: This helps mothers in labor and their doctors make informed choices about pain management without worrying about harming their premature babies.

Plain English
This study looked at how pneumonia from COVID-19 affects the long-term risk of dying from heart disease in people with type 2 diabetes compared to pneumonia from other causes. It found that those hospitalized with COVID-19 pneumonia had a 9.13 times higher risk of cardiovascular death shortly after being treated, which is worse than the 7.3 times increased risk seen with non-COVID pneumonia. While both types of pneumonia increase heart disease death risk over time, the urgent risk from COVID-19 pneumonia diminishes within a few months. Who this helps: This information helps doctors better assess the heart health risks for diabetes patients who have had pneumonia.

Plain English
This study examined how often and what types of patient subgroups are reported in clinical trials for chronic diseases. Out of 2,235 trials reviewed, only 23% (or 524 trials) included information about different patient subgroups such as age, gender, and race, which are important for understanding how treatments might work differently for various people. This is important because it highlights gaps in reporting that could affect patient care and treatment outcomes, showing a lack of data on factors like mental health and comorbid conditions. Who this helps: This research benefits patients and doctors by addressing the need for more inclusive data in clinical trials.

Plain English
This study looked at how cancer-related weight loss, known as cachexia, affects physical abilities over time in a new animal model. Researchers found that using a lower dose of cancer cells allowed them to track changes in physical function for up to 9 weeks. They discovered that gait speed decreased significantly by 2 weeks after cancer implantation, indicating a clearer link to cachexia than grip strength, which showed changes later. Who this helps: This helps doctors and researchers working with cancer patients to better understand and monitor cachexia.

Plain English
This research looked at how frailty is measured in clinical trials, which test new treatments to see how they work. The study reviewed 415 trials and found that frailty was assessed for various reasons, such as to select participants (in 166 trials), to measure treatment outcomes (in 156 trials), or to see how frailty impacts treatment effects (in 61 trials). Most trials used one of 28 different methods to measure frailty, with the frailty phenotype model being the most common. Who this helps: This helps doctors and researchers understand how to better assess frailty in patients, leading to more effective treatments.

Plain English
This study looked at how well sub-Saharan Africa (SSA) is represented in clinical trials that shape treatment guidelines for serious heart conditions, specifically acute coronary syndrome (ACS) and heart failure (HF). It found that a staggering 75.9% of trials were only conducted in high-income countries, with South Africa being the only SSA country involved, contributing to 14.2% of HF and 8.2% of ACS trials. This lack of representation is important because it means that treatments recommended in global guidelines may not work as well for patients in SSA. Who this helps: This helps patients in sub-Saharan Africa by highlighting the need for more inclusive clinical trials.

Plain English
This study looked at patients undergoing heart surgery who are at very high risk of future heart problems. It found that using a step-by-step approach to lower bad cholesterol can help almost all of these patients reach recommended levels, potentially reducing their chances of serious heart events by about 4.6% over ten years. This is important because many patients currently do not meet the cholesterol target, and this method can provide an effective and cost-efficient way to manage their health. Who this helps: This helps patients with heart disease and their doctors.

Plain English
This study looked at the effects of new guidelines for diagnosing chronic kidney disease (CKD) in primary care and how they impact referrals to kidney specialists. It found that the updated kidney function calculations led to fewer new CKD diagnoses in white patients, while CKD rates increased in Black patients. Additionally, only a small number of patients at high risk were identified for further evaluation, and albuminuria testing, which is crucial for kidney health, remained low at under 30%. Who this helps: This benefits patients, especially those from minority ethnic groups at higher risk of kidney failure.

Plain English
This study looked at how a score that measures eight key health factors—called the Life's Essential 8 (LE8) score—relates to major heart and stroke problems in over 250,000 people from the UK Biobank. It found that people with the lowest LE8 scores were more than twice as likely to suffer serious cardiovascular events compared to those with the highest scores, especially younger individuals, women, and ethnic minorities. Improving the health scores of those who are doing poorly could potentially prevent a significant number of these events, demonstrating the importance of targeted health interventions. Who this helps: This research benefits patients at risk for heart disease and healthcare providers working to prevent cardiovascular problems.

Plain English
This study looked at how common frailty is among people with Chronic Obstructive Pulmonary Disease (COPD) and how it affects their health. Researchers found that frailty affects between 2.6% and 80.9% of patients, depending on how it is measured, and it increases the chances of serious problems like death, hospital stays, and worsening COPD symptoms. Understanding frailty helps doctors better manage patients and choose the right treatments. Who this helps: Patients with COPD and their healthcare providers.

Plain English
This study looked at whether COVID-19 vaccination or infection increases the risk of major birth defects when the mother is vaccinated or infected shortly before or during early pregnancy. Researchers analyzed health records from Scotland and found that out of 6,731 vaccinated mothers, only 153 had babies with any major birth defect, showing no increased risk associated with vaccination (the risk ratio was 1.01) or infection (risk ratio was 1.02). This is important because it reassures expectant mothers that getting vaccinated against COVID-19, especially with mRNA vaccines like Pfizer and Moderna, is safe during early pregnancy. Who this helps: This helps pregnant women and their healthcare providers.

Plain English
This study looked at how common frailty is among stroke survivors and how it affects their health outcomes. Researchers analyzed data from nearly 10,000 stroke survivors and found that about 24% identified as frail, with higher percentages when using different assessment methods: 30% were moderately or severely frail, and nearly 32% had severe frailty. Those who were frail were more likely to face serious health issues, such as dying or being readmitted to the hospital within two years. Who this helps: This information is valuable for healthcare providers and patients, particularly those living with the aftereffects of a stroke.

Plain English
This study examined how many US veterans with certain heart and blood vessel diseases—specifically peripheral arterial disease (PAD) and cerebrovascular disease (CeVD)—are getting a drug called PCSK9 inhibitors that lowers bad cholesterol. Out of over half a million veterans with these conditions, only 0.4% started on this medication, with most of those patients having coronary artery disease (CAD). Veterans with PAD and CeVD were significantly less likely to receive this treatment, showing a disparity based on diagnosis, income, and community circumstances. Who this helps: This benefits patients with PAD and CeVD who may not be receiving necessary cholesterol-lowering treatment.

Plain English
This study looked at whether clinical trials accurately represent older patients who often have multiple health issues. Researchers analyzed data from 483 trials involving over 636,000 individuals and compared the number of serious health problems (like hospitalizations and deaths) in these trials to routine healthcare data. They found that for most conditions, trial participants had significantly fewer serious health issues than expected, with a median ratio of 0.60, meaning many were healthier than typical older patients in the community, which raises concerns about how well these trials apply to real-life patients. Who this helps: This helps older patients and healthcare providers by highlighting the importance of including them in research to improve treatment relevance.

Plain English
This study focused on creating new versions of a compound called triphenylphosphonium (TPP) to better target cancer cells. Researchers developed specific TPP analogs, like pMeO-MMe and pCF-MMe, which are designed to be more selective for cancer cells and less harmful to healthy cells. They also found effective ways to detect these compounds in cancer cells and mouse tissue using a special imaging technique. Who this helps: This benefits cancer patients by potentially improving the effects of cancer treatments and reducing side effects.

Plain English
This study looked at how different sources of medical data affect the measurement of multimorbidity, which means having multiple chronic health conditions, in over 2.3 million people in Wales. It found that looking at combined data from primary care and hospital admissions identified 32.2% of people with multimorbidity, compared to just 16.5% when only hospital data was used. Additionally, more younger individuals and more women were found to have multimorbidity when using linked data, highlighting the need for careful data use to avoid underestimating health issues, especially mental health problems. Who this helps: This helps patients with multiple health conditions and healthcare providers make better-informed decisions.

Plain English
This study looked at how effective a surgical procedure called medial patellofemoral ligament (MPFL) reconstruction is when using a donated tissue (allograft) compared to using a patient's own tissue (autograft). The analysis found that only 2.7% of patients who had allograft surgery experienced a recurrence of their knee instability, compared to 7.8% for those who had autograft surgery. Additionally, patients reported high satisfaction with an average Kujala score of 91.8, and 81.5% were able to return to their sports. Who this helps: This benefits patients with knee instability, especially young athletes.

Plain English
This study looked at how walking speed can be used to understand physical decline in cancer patients suffering from cachexia, a condition that leads to weight loss and muscle wasting. The researchers found that changes in walking speed were noticeable as early as two weeks after cancer cell implantation in animal models, and in cancer patients, a faster decline in walking speed was clearly related to their functional independence during rehabilitation efforts. This is important because using walking speed as a measure can help doctors better assess and address the physical challenges that cancer patients face. Who this helps: Patients with cancer and cachexia, as well as their healthcare providers.

Plain English
This study looked at how common frailty is among people with rheumatoid arthritis (RA) and how it relates to their disease activity, hospital stays, and overall death rates. Researchers found that 12% of patients in a Scottish RA group were moderately frail, and 20% in a UK group fell into the same category, with even higher rates for severe frailty. Frailty was linked to a higher risk of death (4.14 times more likely for those moderately or severely frail) and hospitalizations (2.27 times more likely), but improving disease activity through treatment helped reduce frailty levels over time. Who this helps: This research benefits patients with rheumatoid arthritis by highlighting the importance of managing their disease to reduce frailty and its risks.

Plain English
This study focused on whether patients should receive preventive treatment for blood clots after knee surgery, specifically arthroscopy and soft tissue reconstruction. An international group of 38 knee surgeons reached agreement on six key points, indicating that certain patients—especially older individuals or those with a history of blood clots—should receive this preventive care due to increased risks. Establishing these guidelines helps doctors make better decisions about patient care, potentially reducing serious complications like venous thromboembolism. Who this helps: This helps patients undergoing knee surgery by improving their safety and reducing the risk of blood clots.

Plain English
This paper examines criticisms made by Brummett and Crutchfield against religious believers (theists) who oppose the idea of moral enhancement, which is about improving people's moral behavior through various means. The authors found that these critiques misunderstood theists' views, arguing that theists do not necessarily contradict themselves and that their beliefs about virtue and moral behavior are more nuanced than suggested. This matters because it highlights the importance of accurately representing different viewpoints in ethical discussions, allowing for a better understanding of complex moral issues. Who this helps: This helps patients and theists who are engaged in discussions about moral behavior and improvement.

Plain English
This study looks at a new way to deliver measles and rubella vaccines using a microneedle patch for different age groups: healthy adults (ages 18-40), toddlers (15-18 months), and infants (9-10 months). The researchers found that the microneedle patch could be safe and effective for administering the vaccine, which might lead to higher vaccination rates, especially in low-resource areas. This matters because easier and less painful vaccination methods could help eliminate measles and rubella in those communities. Who this helps: Patients and families in low- and middle-income countries.

Plain English
This study examined a large group of people with diabetes in Scotland, known as the Scottish Diabetes Research Network National Diabetes Dataset, which includes over 472,000 individuals who had diabetes from 2006 to 2020. Most (88.1%) of these individuals had type 2 diabetes, and the data collected from various medical records has helped researchers understand issues like the impact of diabetes medications, the risks of COVID-19 for people with diabetes, and trends in diabetes-related deaths. This information is crucial because it helps shape healthcare strategies and guidelines for managing diabetes more effectively. Who this helps: This benefits patients and healthcare providers by improving diabetes care and treatment strategies.

Plain English
This study looked at the effectiveness of three types of diabetes medications—SGLT2 inhibitors, GLP1 receptor analogues, and DPP4 inhibitors—by comparing trial results to a real-world group of people with type 2 diabetes in Scotland. The researchers are using a unique method to include data from various trials to see how well these medications work for people who are typically older and less healthy than those in clinical trials. This matters because it helps ensure that the findings from these trials are relevant to everyday patients, improving treatment decisions for many. Who this helps: This helps patients with type 2 diabetes and their doctors.

Plain English
This study looked at how modifying a compound called triphenylphosphonium (TPP) could make a cancer detection tool, mito-metformin (MMe), more effective and safer for targeting cancer cells. Researchers created new versions of MMe and found that one version, CF-MMe, was better at selectively targeting cancer cells while also allowing for easier tracking of its presence in cells. This is important because it could lead to more effective and less harmful ways to target solid tumors with treatments. Who this helps: This helps cancer patients by improving targeted therapies and monitoring.

Plain English
This study compared health outcomes related to multiple long-term conditions in two groups: participants from the UK Biobank and a more diverse national sample. The researchers found that the UK Biobank had fewer cases of multiple health conditions and underestimated the risks of severe outcomes like death and hospitalization when individuals had four or more conditions. This matters because it highlights that relying on data from the UK Biobank might lead to underestimating risks for patients with complex health needs. Who this helps: This helps doctors and healthcare planners better understand risks for patients with multiple long-term conditions.

Plain English
This study looked at the prevalence of frailty and multiple health conditions, known as multimorbidity, in middle-aged adults with type 2 diabetes. Researchers found that 42% of these individuals were identified as frail or having multimorbidity by at least one measure, and the risk of death, cardiovascular issues, and other complications increased significantly with age and frailty level. For example, men aged 65 with frailty had a 9.9% chance of dying within five years, compared to just 1.9% for those aged 45. Who this helps: This research benefits patients with type 2 diabetes, especially those who are middle-aged and have additional health concerns.

Plain English
This study looked at the safety records (serious adverse events or SAEs) from hypertension drug trials, particularly comparing older adults to younger patients. It found that older adult trials had more SAEs (0.18 events per person per year) than standard trials (0.11 events), but both trial groups reported fewer SAEs than what was expected based on community rates (4.35 for older adults and 3.70 for younger patients). This matters because it highlights that the safety data from these trials may not accurately reflect real-life risks for older patients, suggesting that doctors should be careful when applying trial results to this age group. Who this helps: Older patients with hypertension and their doctors.

Plain English
This study looked at the trends in knee surgeries, particularly a procedure called meniscal allograft transplantation (MAT), in New York from 2005 to 2014. Between these years, over half a million knee procedures were done, but MATs were quite rare—only 117 were performed. However, the number of MATs grew significantly, particularly with an 86.5% jump from 2013 to 2014, and one in four patients who had MAT went on to need another knee surgery. Who this helps: This information helps patients considering MAT and their doctors by highlighting the potential need for future knee surgeries after the procedure.

Plain English
This study looked at brain scans of college athletes in high-contact sports like football and compared them to athletes in low-contact sports like volleyball, to see if there were any differences in brain structure related to repeated head injuries. The researchers found that football players had a longer cavum septum pellucidum, a thin space in the brain, than volleyball players, with a measurement of 0.02. However, other brain metrics were similar between the two groups, indicating that not all aspects of brain structure are affected by high-contact sports. Who this helps: This information benefits athletes, coaches, and medical professionals who monitor the effects of sports-related head trauma.

Plain English
This study looked at how often people with chronic kidney disease (CKD) end up in the hospital compared to those without CKD, especially when they have multiple long-term health issues. Researchers found that in over 469,000 people from the UK Biobank, those with CKD had an average of 3 long-term conditions, while those without had just 1. Similarly, in a larger group from a routine care database in Wales, CKD patients averaged 5 conditions, leading to hospitalisation rates that were 7 to 10 times higher if CKD was present alongside other health issues. Who this helps: This research helps patients with chronic kidney disease and their doctors by highlighting the high risk of hospitalisation they face due to multiple health problems.

Plain English
This study looked at how common frailty is among people with rheumatoid arthritis and how it affects their health. They found that frailty affects between 10% and 36% of adults with rheumatoid arthritis, depending on how it's measured, and is strongly linked to worse disease activity, lower physical ability, and more hospitalizations. Understanding frailty in these patients is important because it can help doctors better manage their care and improve their quality of life. Who this helps: Patients with rheumatoid arthritis and their healthcare providers.